
|Articles|February 7, 2004
Syndrome X - identification and treatment
Washington D.C. - Stephen E. Chiarello, M.D., began his presentationat the AAD annual meeting yesterday by asking those attending the sessionhow many had heard of Syndrome X. Based on the number of hands raised, hesaid that more dermatologists seem to be aware of this condition, also calledMetabolic Syndrome, which affects 90 million Americans and finds its rootsin high glycerin and insulin levels.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
JAK Inhibitors Show Comparable Safety to TNF Antagonists
3
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 1
5


















